Form 4 for CNMD CONMED Corp
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001127602-23-008749 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-03 | 2023-03-02 | CNMD | Jonas Daniel S | Special Counsel, Corp Secy | S - Sale+OE | $96.17 | -10.4K | 14.0K | -43% | -$1.00M |
| DM | 2023-03-03 | 2023-03-01+ | CNMD | Jonas Daniel S | Special Counsel, Corp Secy | M - OptEx | $55.63 | +12.9K | 14.8K | +685% | +$717.6K |
| D | 2023-03-03 | 2023-03-01 | CNMD | Jonas Daniel S | Special Counsel, Corp Secy | F - Tax | $96.16 | -736 | 14.0K | -5% | -$70.8K |
| DM | 2023-03-03 | 2023-03-01+ | CNMD | Jonas Daniel S | Special Counsel, Corp Secy | M - OptEx | $0.00 | -12.9K | 5,000 | -72% | $0 |
| D | 2023-03-03 | 2023-03-01 | CNMD | Jonas Daniel S | Special Counsel, Corp Secy | A - Grant | $0.00 | +3,000 | 3,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-02 | S | D | 5,000 | $96.08 | 14,048 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $96.24. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 2 | Common | Common Stock | 2023-03-02 | M | A | 5,000 | $78.76 | 19,048 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-02 | S | D | 5,400 | $96.25 | 14,048 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-02 | M | A | 5,400 | $59.96 | 19,448 | D | — | — | |
| 5 | Common | Common Stock | 2023-03-01 | M | A | 2,500 | $0.00 | 14,784 | D | — | — | |
| 6 | Common | Common Stock | 2023-03-01 | F | D | 736 | $96.16 | 14,048 | D | — | — | |
| 7 | Derivative | Options To Purchase Common Stock | 2023-03-02 | M | D | 5,400 | $0.00 | 0 | D | $59.96 · — to 2028-03-01 | 5,400 Common Stock | (F4) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 8 | Derivative | Rsus (restricted Stock Units) | 2023-03-01 | A | A | 3,000 | $0.00 | 3,000 | D | $0.00 · — to 2033-03-01 | 3,000 Common Stock | (F3) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting in equal amounts (1000 units) over a three year period. |
| 9 | Derivative | Rsus (restricted Stock Units) | 2023-03-01 | M | D | 2,500 | $0.00 | 0 | D | $0.00 · — to 2032-03-01 | 2,500 Common Stock | (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period. |
| 10 | Derivative | Options To Purchase Common Stock | 2023-03-02 | M | D | 5,000 | $0.00 | 5,000 | D | $78.76 · — to 2029-03-01 | 5,000 Common Stock | (F5) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |